Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Recommendations on Interferon Gamma Release Assaysfor the Diagnosis of Latent Tuberculosis Infection-2010 Update: An Advisory Committee Statement (ACS) Canadian Tuberculosis Committee (CTC)*†.

Literature DB >> 31701952

Recommendations on Interferon Gamma Release Assaysfor the Diagnosis of Latent Tuberculosis Infection-2010 Update: An Advisory Committee Statement (ACS) Canadian Tuberculosis Committee (CTC)*^†.

Dennis Kunimoto, Drs Michael Gardam, Ian Kitai, Dick Menzies, Muhammad Morshed, Madhukar Pai, Heather Ward, Duncan Webster, Wendy Wobeser.

Abstract

Entities: Disease

Year: 2010 PMID： 31701952 PMCID： PMC6802443 DOI： 10.14745/ccdr.v36i00a05

Source DB: PubMed Journal: Can Commun Dis Rep ISSN： 1188-4169

Keyword Cloud
References

× No keyword cloud information.

13 in total

1. Use of incentives to increase compliance for TB screening in a population of intravenous drug users. Vancouver Injection Drug Use Study Group.

Authors: J M FitzGerald; D M Patrick; S Strathdee; M Rekart; R K Elwood; M T Schecter; J Montaner; M O'Shaughnessy
Journal: Int J Tuberc Lung Dis Date: 1999-02 Impact factor: 2.373

2. Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis.

Authors: O Oxlade; K Schwartzman; D Menzies
Journal: Int J Tuberc Lung Dis Date: 2007-01 Impact factor: 2.373

3. Cost-effectiveness of a new interferon-based blood assay, QuantiFERON-TB Gold, in screening tuberculosis contacts.

Authors: F Marra; C A Marra; M Sadatsafavi; O Morán-Mendoza; V Cook; R K Elwood; M Morshed; R C Brunham; J M Fitzgerald
Journal: Int J Tuberc Lung Dis Date: 2008-12 Impact factor: 2.373

4. Updated recommendations on interferon gamma release assays for latent tuberculosis infection. An Advisory Committee Statement (ACS).

Authors:
Journal: Can Commun Dis Rep Date: 2008-10

5. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research.

Authors: Dick Menzies; Madhukar Pai; George Comstock
Journal: Ann Intern Med Date: 2007-03-06 Impact factor: 25.391

6. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis.

Authors: Roland Diel; Robert Loddenkemper; Karen Meywald-Walter; Stefan Niemann; Albert Nienhaus
Journal: Am J Respir Crit Care Med Date: 2008-02-14 Impact factor: 21.405

Recommendations on Interferon Gamma Release Assaysfor the Diagnosis of Latent Tuberculosis Infection-2010 Update: An Advisory Committee Statement (ACS) Canadian Tuberculosis Committee (CTC)*^†.

1. Use of incentives to increase compliance for TB screening in a population of intravenous drug users. Vancouver Injection Drug Use Study Group.

2. Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis.

3. Cost-effectiveness of a new interferon-based blood assay, QuantiFERON-TB Gold, in screening tuberculosis contacts.

4. Updated recommendations on interferon gamma release assays for latent tuberculosis infection. An Advisory Committee Statement (ACS).

5. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research.

6. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis.

Review 7. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update.

8. Cost effectiveness of interferon-gamma release assay for tuberculosis contact screening in Japan.

9. Cost-effectiveness of interferon-gamma release assay testing for the treatment of latent tuberculosis.

10. Serial testing for tuberculosis: can we make sense of T cell assay conversions and reversions?